<DOC>
	<DOCNO>NCT02558023</DOCNO>
	<brief_summary>The objective study demonstrate urapidil inferior nicardipine treatment hypertension associate preeclampsia ( PE ) well tolerate . - efficacy endpoint : mean arterial blood pressure correct 100-120 mmHg 120 min study drug administration . - safety endpoint : clinical biological observation side effect . All infant observe neonatology unit ( 48h ) . Pharmacokinetic study include study : - transplacental transfer , - transfer breast milk , - neonatal elimination ( premature baby mother treat urapidil ( less 33 WG ) )</brief_summary>
	<brief_title>The Treatment Hypertension Associated With Severe Preeclampsia ( PE ) . A Trial Urapidil Versus Nicardipine</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Pre-Eclampsia</mesh_term>
	<mesh_term>Urapidil</mesh_term>
	<mesh_term>Nicardipine</mesh_term>
	<mesh_term>Benzocaine</mesh_term>
	<criteria>Adult patient Singleton pregnancy Patients remain hypertension despite oral treatment iv antihypertensive treatment indicate Patient PE , define : Systolic Blood Pressure ( BP ) ≥ 140 mmHg and/or Diastolic BP ≥ 90 mmHg , 20th week amenorrhea , without chronic hypertension , AND Proteinuria &gt; 300 mg.day1 &gt; 2 cross ( ++ ) urinary dipstick , OR Patient severe Pregnancy Induced Hypertension ( PIH ) , define : Systolic BP ≥ 160 mmHg and/or Diastolic BP ≥110 mmHg , 20th week amenorrhea , without chronic hypertension , Written inform consent sign dated investigator patient , Valid social security affiliation Known allergy study drug Contraindication study drug : stenosis aortic isthmus , arteriovenous shunt , coarctation aorta , unstable angina , compensatory hypertension , myocardial infarction &lt; 8 day . Eclampsia Person difficulty understand information Person diminish responsibility , Ongoing intravenous antihypertensive treatment , No pressure cuff adapt morphology arm patient Concomitant use 5 phosphodiesterase inhibitor Participation clinical trial within 6 month prior inclusion</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2015</verification_date>
	<keyword>PRE-ECLAMPSIA</keyword>
	<keyword>URAPIDIL</keyword>
	<keyword>NICARDIPINE</keyword>
</DOC>